McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Covid-19 serves as catalyst for effort to diversity clinical trial enrollment

by McKesson Ventures | Apr 23, 2021 | Media Coverage

McKesson Ventures Vice President and Partner Carrie Williams was a speaker on a panel at MedCity’s INVEST conference, April 22, 2021. She and the other panelists, Allison Kalloo, founder and president of Clinical Ambassador; Doug Langa, executive vice president of...

McKesson Ventures highlights investment priorities amidst a trail of successful exits

by McKesson Ventures | Apr 20, 2021 | Media Coverage

In a recent interview, McKesson Ventures Partner Michelle Snyder discussed the latest trends in digital health and how McKesson Ventures chooses its investments. As a corporate venture group, the McKesson Ventures team is well positioned to identify emerging trends in...

McKesson Ventures Expands Portfolio Development Team and Invests in Market Research

by McKesson Ventures | Jan 7, 2021 | Press Releases

McKesson Ventures has added Lizzie Lee as its newest team member. She joins the firm as senior director, leading its portfolio development and market research efforts. With a decade of healthcare experience, Lee is well-positioned to help McKesson Ventures’ portfolio...

McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care

by McKesson Ventures | Dec 3, 2020 | Press Releases

McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer. Building on McKesson’s long history in...

Michelle Snyder, Digital Health Veteran, Joins McKesson Ventures

by McKesson Ventures | Dec 1, 2020 | Press Releases

McKesson Ventures has hired Michelle Snyder as its newest investment partner. Snyder, a mobile health pioneer, is known for her leadership and guidance in building Epocrates, one of the healthcare industry’s first successful mobile health companies. She brings more...
Page 3 of 10«12345...10...»Last »

Recent Posts

  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
  • Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care

Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation

Komodo Health Introduces Marmot, the AI Built to Accelerate Healthcare Innovation

Atropos Health Enters into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow